By further using a TMA containing 80 HCC patients, we not only confirmed a higher number of CD103+ cells in cancer, but also found a positive correlation between the number of CD103+ cells and better prognoses (P = 0.028). This evidence concerns the gene ITGAE and hepatocellular carcinoma.